Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

USA - NASDAQ:BYRN - US12448X2018 - Common Stock

24.95 USD
+0.36 (+1.46%)
Last: 10/14/2025, 8:00:02 PM
25.0999 USD
+0.15 (+0.6%)
After Hours: 10/14/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, BYRN scores 6 out of 10 in our fundamental rating. BYRN was compared to 69 industry peers in the Aerospace & Defense industry. While BYRN has a great health rating, its profitability is only average at the moment. BYRN is valued quite expensively, but it does show have an excellent growth rating. This makes BYRN very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year BYRN was profitable.
BYRN had a negative operating cash flow in the past year.
BYRN had negative earnings in 4 of the past 5 years.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

The Return On Assets of BYRN (20.36%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 25.33%, BYRN belongs to the best of the industry, outperforming 94.20% of the companies in the same industry.
The Return On Invested Capital of BYRN (14.57%) is better than 94.20% of its industry peers.
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROIC 14.57%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN has a better Profit Margin (14.43%) than 91.30% of its industry peers.
The Operating Margin of BYRN (10.81%) is better than 69.57% of its industry peers.
The Gross Margin of BYRN (61.32%) is better than 94.20% of its industry peers.
BYRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BYRN is still creating some value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
Compared to 5 years ago, BYRN has more shares outstanding
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 23.75. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
BYRN has a Altman-Z score of 23.75. This is amongst the best in the industry. BYRN outperforms 97.10% of its industry peers.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.75
ROIC/WACC1.51
WACC9.68%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 4.21 indicates that BYRN has no problem at all paying its short term obligations.
BYRN's Current ratio of 4.21 is amongst the best of the industry. BYRN outperforms 86.96% of its industry peers.
A Quick Ratio of 1.71 indicates that BYRN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.71, BYRN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 1.71
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

BYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 235.00%, which is quite impressive.
BYRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.99%.
Measured over the past years, BYRN shows a very strong growth in Revenue. The Revenue has been growing by 147.68% on average per year.
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%

3.2 Future

The Earnings Per Share is expected to grow by 16.05% on average over the next years. This is quite good.
BYRN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.79% yearly.
EPS Next Y-38.47%
EPS Next 2Y6.54%
EPS Next 3Y16.05%
EPS Next 5YN/A
Revenue Next Year36.96%
Revenue Next 2Y29.13%
Revenue Next 3Y29.15%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.24, which means the current valuation is very expensive for BYRN.
BYRN's Price/Earnings ratio is a bit cheaper when compared to the industry. BYRN is cheaper than 68.12% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. BYRN is valued slightly more expensive when compared to this.
BYRN is valuated quite expensively with a Price/Forward Earnings ratio of 35.45.
BYRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BYRN is cheaper than 60.87% of the companies in the same industry.
BYRN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.24
Fwd PE 35.45
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.76
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of BYRN may justify a higher PE ratio.
A more expensive valuation may be justified as BYRN's earnings are expected to grow with 16.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.54%
EPS Next 3Y16.05%

More info and screens

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (10/14/2025, 8:00:02 PM)

After market: 25.0999 +0.15 (+0.6%)

24.95

+0.36 (+1.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-09 2025-10-09/bmo
Earnings (Next)12-08 2025-12-08/bmo
Inst Owners65.32%
Inst Owner Change0%
Ins Owners19.32%
Ins Owner Change0.07%
Market Cap567.11M
Analysts83.64
Price Target39.27 (57.39%)
Short Float %22.61%
Short Ratio8.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.45%
Min EPS beat(2)21.04%
Max EPS beat(2)37.87%
EPS beat(4)4
Avg EPS beat(4)102.42%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)7
Avg EPS beat(8)85.45%
EPS beat(12)9
Avg EPS beat(12)5.69%
EPS beat(16)10
Avg EPS beat(16)-7.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)7.51%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)0%
PT rev (3m)7.32%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-29.28%
EPS NY rev (1m)-5.08%
EPS NY rev (3m)6.86%
Revenue NQ rev (1m)2.32%
Revenue NQ rev (3m)2.37%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 37.24
Fwd PE 35.45
P/S 5.12
P/FCF N/A
P/OCF N/A
P/B 8.98
P/tB 9.82
EV/EBITDA 39.76
EPS(TTM)0.67
EY2.69%
EPS(NY)0.7
Fwd EY2.82%
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS4.88
BVpS2.78
TBVpS2.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROCE 18.44%
ROIC 14.57%
ROICexc 16.91%
ROICexgc 18.72%
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 340.6%
Cap/Sales 6.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 1.71
Altman-Z 23.75
F-Score7
WACC9.68%
ROIC/WACC1.51
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y-38.47%
EPS Next 2Y6.54%
EPS Next 3Y16.05%
EPS Next 5YN/A
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%
Revenue Next Year36.96%
Revenue Next 2Y29.13%
Revenue Next 3Y29.15%
Revenue Next 5Y18.79%
EBIT growth 1Y601.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.26%
EBIT Next 3Y92.43%
EBIT Next 5Y53.44%
FCF growth 1Y-82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.34%
OCF growth 3YN/A
OCF growth 5YN/A